AXL Mediates TRAIL Resistance in Esophageal Adenocarcinoma
The overexpression of AXL receptor tyrosine kinase is a frequent finding that has been associated with poor prognosis in esophageal adenocarcinoma (EAC). As the majority of EAC are intrinsically resistant to DNA-damaging therapies, an alternative therapeutic approach based on the activation of deat...
Main Authors: | Jun Hong, Abbes Belkhiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558613800589 |
Similar Items
-
Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
by: Jun Hong, et al.
Published: (2018-12-01) -
AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking
by: Selma Maacha, et al.
Published: (2018-10-01) -
Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
by: Rama Saad, et al.
Published: (2013-01-01) -
The Synergistic Effects of Low Dose Fluorouracil and TRAIL on TRAIL-Resistant Human Gastric Adenocarcinoma AGS Cells
by: Hong Zhu, et al.
Published: (2013-01-01) -
Expression of Axl in Lung Adenocarcinoma and Correlation with Tumor Progression
by: Yi-Shing Shinh, et al.
Published: (2005-12-01)